DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 5BUDESONIDE
02 1DEXILANT
03 2DIMETHYL FUMARATE
04 1ENTOCORT EC
05 2ESOMEPRAZOLE MAGNESIUM
06 1ESOMEPRAZOLE STRONTIUM
07 2FENOFIBRIC ACID
08 1NEXIUM 24HR
09 1OMEPRAZOLE MAGNESIUM
10 1ORTIKOS
01 121324
02 122287
03 178878
04 190379
05 190410
06 1200913
07 1202342
08 1204655
09 1206134
10 1206623
11 1206724
12 1207193
13 1209339
14 1210305
15 1210309
16 1211626
17 1211929
01 15No
02 2Yes
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : BUDESONIDE
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 206623
Country : US
Patented : No
Drug : NEXIUM 24HR
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 204655
Country : US
Patented : No
Drug : ESOMEPRAZOLE MAGNESIUM
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 209339
Country : US
Patented : No
Drug : BUDESONIDE
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 90410
Country : US
Patented : No
Drug : BUDESONIDE
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 90379
Country : US
Patented : No
Drug : DIMETHYL FUMARATE
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 210309
Country : US
Patented : No
Drug : FENOFIBRIC ACID
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 211626
Country : US
Patented : No
Drug : DEXILANT
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 22287
Country : US
Patented : Yes
Drug : BUDESONIDE
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 206134
Country : US
Patented : No
Drug : FENOFIBRIC ACID
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 200913
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
